Skip to main content
SpringerLink
Log in

Allopurinol/azathioprine

Various toxicities: 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • van Liere ELSA, et al. Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases. Digestive Diseases and Sciences 67: 4008-4019, No. 8, Aug 2022. Available from: URL: http://doi.org/10.1007/s10620-021-07273-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allopurinol/azathioprine. Reactions Weekly 1921, 19 (2022). https://doi.org/10.1007/s40278-022-22013-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-22013-2

Search

Navigation